Plain-English translation of NCT06895252 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether fecal microbiota transplantation (FMT)—a procedure where healthy stool from a donor is placed in your colon—combined with an anti-inflammatory diet can help treat newly diagnosed ulcerative colitis. All participants also receive 5-aminosalicylic acid, a standard medication for this condition. The study wants to see if these newer approaches, either alone or together, work better than the medication alone.
Ulcerative colitis is a serious bowel condition that causes ongoing inflammation and symptoms. While the medication used here helps some patients, researchers believe that changing the bacteria in your gut (the microbiome) through transplant and diet modifications might offer additional benefits and help more people achieve long-lasting relief.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of four groups: some will receive the fecal transplant procedure plus a special diet, some will receive the transplant with a standard diet, some will receive the special diet alone, and some will receive standard care only (all groups also take the medication). If you receive the transplant, you'll have three procedures during the first 6 weeks, then additional treatments over the next 9 months if your disease improves. You'll also receive dietary guidance and use a mobile app to track your eating. The study lasts 48 weeks total, and you'll have regular follow-up visits to check how you're doing.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
India